BRPI0821034A8 - Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação - Google Patents
Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicaçãoInfo
- Publication number
- BRPI0821034A8 BRPI0821034A8 BRPI0821034A BRPI0821034A BRPI0821034A8 BR PI0821034 A8 BRPI0821034 A8 BR PI0821034A8 BR PI0821034 A BRPI0821034 A BR PI0821034A BR PI0821034 A BRPI0821034 A BR PI0821034A BR PI0821034 A8 BRPI0821034 A8 BR PI0821034A8
- Authority
- BR
- Brazil
- Prior art keywords
- influenza
- virus
- gene
- preparation
- well
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 6
- 238000000034 method Methods 0.000 title abstract 5
- 241000713196 Influenza B virus Species 0.000 title abstract 4
- 241000700605 Viruses Species 0.000 title abstract 4
- 206010022000 influenza Diseases 0.000 title abstract 4
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 230000002950 deficient Effects 0.000 title abstract 2
- 108020004707 nucleic acids Proteins 0.000 title abstract 2
- 150000007523 nucleic acids Chemical class 0.000 title abstract 2
- 102000039446 nucleic acids Human genes 0.000 title abstract 2
- 230000010076 replication Effects 0.000 title abstract 2
- 239000002773 nucleotide Substances 0.000 abstract 2
- 125000003729 nucleotide group Chemical group 0.000 abstract 2
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 241000712461 unidentified influenza virus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/145—Orthomyxoviridae, e.g. influenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16211—Influenzavirus B, i.e. influenza B virus
- C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
VÍRUS INFLUENZA B RECOMBINANTE, SEU USO, MÉTODO DE PREPARAÇÃO, COMPOSIÇÃO DE VACINA O CONTENDO E SEU GENE M, BEM COMO ÁCIDO NUCLÉICO ISOLADO, MOLÉCULA DO VÍRUS INFLUENZA M E SEU USO E MÉTODO PARA AUMENTAR A TAXA DE CRESCIMENTO DE VÍRUS INFLUENZA B DEFICIENTE DE REPLICAÇÃO. A presente invenção refere-se a um gene M do vírus influenza B com uma modificação de pelo menos uma sequência de nucleotídeos próxima à terminação N do gene M, mais especificamente em qualquer uma das posições de nucleotídeos 265 a 294 do gene M bem como um vírus influenza B que compreende o dito gene M modificado. Adicionalmente, são também descritos seu uso na preparação de uma vacina e métodos para preparar o dito vírus influenza modificado.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07450244A EP2072058A1 (en) | 2007-12-21 | 2007-12-21 | Modified influenza virus |
| PCT/EP2008/068154 WO2009080806A2 (en) | 2007-12-21 | 2008-12-22 | Modified influenza virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0821034A2 BRPI0821034A2 (pt) | 2015-06-16 |
| BRPI0821034A8 true BRPI0821034A8 (pt) | 2016-12-13 |
Family
ID=39325504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0821034A BRPI0821034A8 (pt) | 2007-12-21 | 2008-12-22 | Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8592196B2 (pt) |
| EP (2) | EP2072058A1 (pt) |
| JP (1) | JP2011505863A (pt) |
| KR (1) | KR101597633B1 (pt) |
| CN (1) | CN101903043B (pt) |
| AU (1) | AU2008339972A1 (pt) |
| BR (1) | BRPI0821034A8 (pt) |
| CA (1) | CA2705444C (pt) |
| EA (1) | EA024036B1 (pt) |
| MX (1) | MX2010006918A (pt) |
| WO (1) | WO2009080806A2 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2836977A1 (en) * | 2010-06-06 | 2011-12-15 | Benjamin R. Tenoever | Recombinant rna viruses and uses thereof |
| KR101315273B1 (ko) * | 2012-10-29 | 2013-10-08 | 대한민국 | 강독화된 인플루엔자 바이러스 변이주 |
| CN104436157A (zh) | 2013-09-23 | 2015-03-25 | 恩金生物有限公司 | 流感疫苗和治疗 |
| US10080792B2 (en) | 2013-09-23 | 2018-09-25 | Engen Bio, Inc. | Influenza vaccine and therapy |
| KR101582490B1 (ko) | 2014-04-14 | 2016-01-19 | 아이디바이오 주식회사 | 인플루엔자 바이러스의 다중 아형에 대한 교차 면역반응을 형성하는 신규한 재조합 바이러스 백신 |
| US9827304B2 (en) * | 2014-11-13 | 2017-11-28 | The University Of Hong Kong | Live attenuated vaccines for influenza viruses |
| RU2628690C2 (ru) * | 2015-11-06 | 2017-08-21 | Общество С Ограниченной Ответственностью 'Фарминтерпрайсез' | Аттенуированные гриппозные векторы для профилактики и/или лечения инфекционных заболеваний, а также для лечения онкологических заболеваний |
| TWI793059B (zh) * | 2016-04-13 | 2023-02-21 | 香港商港大科橋有限公司 | 用於流感病毒的減弱活疫苗 |
| EP3585884A4 (en) | 2017-02-27 | 2021-04-07 | Flugen, Inc. | INFLUENZA B VIRUS MUTANTS AND USES |
| KR20200103020A (ko) | 2017-12-22 | 2020-09-01 | 코다제닉스 인코포레이티드 | 코돈쌍 탈최적화 영역을 가진 재조합 바이러스 및 암 치료를 위한 이의 용도 |
| CA3091508A1 (en) | 2018-03-08 | 2019-09-12 | Codagenix Inc. | Attenuated flaviviruses |
| CN113166733B (zh) * | 2018-11-16 | 2024-12-31 | 港大科桥有限公司 | 活减毒流感b病毒组合物及其制备和使用方法 |
| CN113853215B (zh) * | 2019-01-24 | 2025-07-18 | 蓝天免疫疗法有限责任公司 | 高生长流感病毒 |
| KR102370100B1 (ko) | 2019-02-15 | 2022-03-07 | 아이디바이오 주식회사 | 이종 인플루엔자 a 바이러스에 대한 면역/치료반응을 형성하는 신규한 재조합 인플루엔자 바이러스 및 이를 포함하는 유전자 전달체 및 치료백신 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MXPA00012402A (es) * | 1998-06-12 | 2003-07-14 | Sinai School Medicine | Metodos y substratos deficientes de interferon, novedosos, para la propagacion de virus. |
| JP4441595B2 (ja) | 1998-06-12 | 2010-03-31 | マウント シナイ スクール オブ メディシン オブ ニューヨーク ユニバーシティー | インターフェロン誘導性の遺伝子工学的に作製された弱毒ウイルス |
| AU2004263813B8 (en) * | 2003-02-25 | 2008-09-11 | Medimmune, Llc | Methods of producing influenza vaccine compositions |
| AT502292B1 (de) | 2005-05-11 | 2010-04-15 | Avir Green Hills Biotechnology | Melanomdiagnose |
| US20070116717A1 (en) * | 2005-08-01 | 2007-05-24 | Shneider Alexander M | Influenza vaccine compositions and methods |
| CN1810961B (zh) * | 2006-02-22 | 2010-05-12 | 中国人民解放军军事医学科学院微生物流行病研究所 | 一种重组流感病毒及其制备方法与应用 |
| US7601356B2 (en) * | 2006-07-21 | 2009-10-13 | Medimmune, Llc | Methods and compositions for increasing replication capacity of an influenza virus |
| EP2048237A1 (en) | 2007-10-05 | 2009-04-15 | Avir Green Hills Biotechnology Research Development Trade Ag | Replication deficient Influenza virus for the expression of heterologous sequences |
| EP2045323A1 (en) | 2007-10-05 | 2009-04-08 | Avir Green Hills Biotechnology Research Development Trade Ag | Linear expression constructs for production of influenza virus particles |
-
2007
- 2007-12-21 EP EP07450244A patent/EP2072058A1/en not_active Withdrawn
-
2008
- 2008-12-22 BR BRPI0821034A patent/BRPI0821034A8/pt not_active IP Right Cessation
- 2008-12-22 JP JP2010538787A patent/JP2011505863A/ja active Pending
- 2008-12-22 AU AU2008339972A patent/AU2008339972A1/en not_active Abandoned
- 2008-12-22 CN CN200880122161.0A patent/CN101903043B/zh active Active
- 2008-12-22 US US12/809,814 patent/US8592196B2/en active Active
- 2008-12-22 CA CA2705444A patent/CA2705444C/en active Active
- 2008-12-22 WO PCT/EP2008/068154 patent/WO2009080806A2/en not_active Ceased
- 2008-12-22 MX MX2010006918A patent/MX2010006918A/es not_active Application Discontinuation
- 2008-12-22 EA EA201001045A patent/EA024036B1/ru not_active IP Right Cessation
- 2008-12-22 KR KR1020107011566A patent/KR101597633B1/ko active Active
- 2008-12-22 EP EP08865597.2A patent/EP2222334B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011505863A (ja) | 2011-03-03 |
| US20100322970A1 (en) | 2010-12-23 |
| CN101903043A (zh) | 2010-12-01 |
| EA024036B1 (ru) | 2016-08-31 |
| BRPI0821034A2 (pt) | 2015-06-16 |
| WO2009080806A2 (en) | 2009-07-02 |
| US8592196B2 (en) | 2013-11-26 |
| EA201001045A1 (ru) | 2010-12-30 |
| EP2222334A2 (en) | 2010-09-01 |
| WO2009080806A3 (en) | 2009-10-08 |
| CA2705444A1 (en) | 2009-07-02 |
| CA2705444C (en) | 2017-04-25 |
| CN101903043B (zh) | 2014-01-22 |
| MX2010006918A (es) | 2010-12-06 |
| KR101597633B1 (ko) | 2016-02-26 |
| AU2008339972A1 (en) | 2009-07-02 |
| EP2072058A1 (en) | 2009-06-24 |
| KR20100102593A (ko) | 2010-09-24 |
| EP2222334B1 (en) | 2014-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0821034A8 (pt) | Vírus influenza b recombinante, seu uso, metodo de preparação, composição de vacina o contendo e seu gene m, bem como ácido nucléico isolado, molécula do vírus influenza m e seu uso e método para aumentar a taxa de crescimento de vírus influenza b deficiente de replicação | |
| BR112016009465A2 (pt) | Vírus herpes simplex oncolítico recombinante (ohsv), ácido nucleico o codificando, estoque viral e composição o compreendendo, bem como seu uso | |
| MX2018001040A (es) | Moleculas de acido nucleico artificiales. | |
| BR112013031021A2 (pt) | composições e métodos para a inibição da expressão de gene do vírus da hepatite b' | |
| BR112015000710A8 (pt) | Oligonucleotídeos para fazer uma alteração na sequência de um presente alvo de molécula de rna em uma célula viva | |
| BR122019013216B8 (pt) | ensaio imunológico para análise de uma vacina contra influenza | |
| AR065076A1 (es) | Vacuna contra el papilomavirus | |
| BR112017014917A2 (pt) | elementos regulatórios pós-transcricionais modificados de hepatite | |
| BR112012015740A2 (pt) | anticorpos de anti-flt3 e metodos de uso dos mesmos | |
| BR112019001887A2 (pt) | composições e métodos para o tratamento de doença associada a cep290 | |
| ES2627330T3 (es) | Uso de JAZ5a para mejorar la resistencia a la sequía en una planta | |
| MX2016008551A (es) | Moleculas artificiales de acido nucleico. | |
| BR112015008708A2 (pt) | composição para clivagem de dna alvo compreendendo um rna guia específico para o dna alvo e ácido nucleico que codifica proteína cas ou proteína cas e uso da mesma | |
| BR112014008694A2 (pt) | moléculas de ácido nucleico policistrônico recombinante | |
| BR112018013808A2 (pt) | dinucleotídeos cíclicos para o tratamento de condições associadas à atividade de sting, tal como câncer | |
| AR090470A1 (es) | Vacuna contra el virus sincicial respiratorio (rsv) | |
| WO2007048089A3 (en) | Multi-plasmid system for the production of influenza virus | |
| BR112017028205A2 (pt) | molécula de rna, vetor, célula hospedeira, composição farmacêutica, kit, e, uso de uma ou mais utrs. | |
| BR112015018493A2 (pt) | Linhagens celulares para produção de vírus e métodos de uso | |
| BR112022016992A2 (pt) | Vacina com base em poxvírus recombinante contra ví-rus sars-cov-2 | |
| BR112014023898A2 (pt) | moléculas de ácido nucleico artificiais compreendendo 5''utr top | |
| WO2005042728A3 (en) | Immortalized avian cell lines for virus production | |
| BRPI0516221A (pt) | método de produção de vìrus de uma cultura de células, composição, e, método de produção de reovìrus infeccioso | |
| BR112015022507A2 (pt) | ácidos ribonucleicos com nucleotídeos 4'-tio-modificados, composição compreendendo o mesmo e usos relacionados | |
| BRPI0922867B8 (pt) | glicoproteina de fusão (f) de vírus sincicial respiratório (rsv), ácido nucleico isolado, célula hospedeira, composição de vacina e micela purificada |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: BAXTER HEALTHCARE S.A (CH) |
|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |